Value through Innovation16 January 2013

A State-of-the-Art Research & Development Environment

At Boehringer Ingelheim, research & development is conducted at four major research & development sites and three support centres in Europe, the Americas and Asia. During the last decade clinical research was conducted in 87 countries all over the world. Key to success in research & development are good people with the best scientific and technological knowledge, flexible thinking and good communication, who work well with their peers inside and outside the company.

Centres & Technologies

  • R&D Centres

    Boehringer Ingelheim's worldwide research, development and support centres.

  • Research Institute IMP

    The bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna (Austria).

  • Technologies

    Boehringer Ingelheim's successful drug discovery relies on excellent interdisciplinary cooperation and well-functioning medicinal chemistry with state-of-the-art tools.

Drug Discovery Process

From discovery to curiosity

From discovery to a marketable drug is a long road, always led by curiosity.

Oncology and white room

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player